Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Related Citations for PubMed (Select 24184223)

1.

Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.

Besley J, Pappalardo J, Lee GA, Hirst LW, Vincent SJ.

Am J Ophthalmol. 2014 Feb;157(2):287-293.e2. doi: 10.1016/j.ajo.2013.10.012. Epub 2013 Nov 1.

PMID:
24184223
2.

Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.

Krilis M, Tsang H, Coroneo M.

Ophthalmology. 2012 Oct;119(10):1969-73. doi: 10.1016/j.ophtha.2012.03.045. Epub 2012 Jun 14.

PMID:
22704834
3.

Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.

Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL.

Ophthalmology. 2014 May;121(5):994-1000. doi: 10.1016/j.ophtha.2013.11.017. Epub 2014 Jan 9.

PMID:
24411578
4.
5.

Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.

Shah SU, Kaliki S, Kim HJ, Lally SE, Shields JA, Shields CL.

Arch Ophthalmol. 2012 Feb;130(2):159-64. doi: 10.1001/archophthalmol.2011.385.

PMID:
22332208
6.

Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.

Kim HJ, Shields CL, Shah SU, Kaliki S, Lally SE.

Ophthalmology. 2012 May;119(5):938-44. doi: 10.1016/j.ophtha.2011.11.035. Epub 2012 Feb 22.

PMID:
22361315
7.

Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.

Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W, Srivannaboon S.

Cornea. 2005 May;24(4):443-8.

PMID:
15829803
8.

Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.

Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Pe'er J, Savir H, Holland EJ, Meisler DM, Foster JA, Folberg R, Rozenman Y.

Ophthalmology. 1997 Dec;104(12):2085-93.

PMID:
9400769
9.

Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.

Bahrami B, Greenwell T, Muecke JS.

Clin Experiment Ophthalmol. 2014 May-Jun;42(4):317-22. doi: 10.1111/ceo.12184. Epub 2013 Sep 13.

PMID:
23927413
10.

Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.

Galor A, Karp CL, Oellers P, Kao AA, Abdelaziz A, Feuer W, Dubovy SR.

Ophthalmology. 2012 Oct;119(10):1974-81. doi: 10.1016/j.ophtha.2012.04.022. Epub 2012 Jun 14.

11.

Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.

Ballalai PL, Erwenne CM, Martins MC, Lowen MS, Barros JN.

Ophthal Plast Reconstr Surg. 2009 Jul-Aug;25(4):296-9. doi: 10.1097/IOP.0b013e3181ac4c39.

PMID:
19617789
12.

Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.

Schechter BA, Koreishi AF, Karp CL, Feuer W.

Ophthalmology. 2008 Aug;115(8):1291-6, 1296.e1. doi: 10.1016/j.ophtha.2007.10.039. Epub 2008 Jan 9.

PMID:
18187195
13.

[Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].

Cartsburg O, Kersten A, Sundmacher R, Nadjari B, Pomjanski N, Böcking A.

Klin Monbl Augenheilkd. 2001 Jun;218(6):429-34. German.

PMID:
11488009
14.

Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.

Vann RR, Karp CL.

Ophthalmology. 1999 Jan;106(1):91-7.

PMID:
9917787
15.

Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.

Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC.

Br J Ophthalmol. 2010 May;94(5):551-4. doi: 10.1136/bjo.2008.153197. Epub 2009 Jun 2.

PMID:
19493859
16.

Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.

Wilson MW, Hungerford JL, George SM, Madreperla SA.

Am J Ophthalmol. 1997 Sep;124(3):303-11.

PMID:
9439356
17.

Topical chemotherapy for ocular surface squamous neoplasia.

Nanji AA, Sayyad FE, Karp CL.

Curr Opin Ophthalmol. 2013 Jul;24(4):336-42. doi: 10.1097/ICU.0b013e3283622a13. Review.

PMID:
23680759
18.

Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.

Kim BH, Kim MK, Wee WR, Oh JY.

Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2569-73. doi: 10.1007/s00417-013-2450-0. Epub 2013 Sep 5.

PMID:
24006080
19.

Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.

Holcombe DJ, Lee GA.

Am J Ophthalmol. 2006 Oct;142(4):568-71.

PMID:
17011846
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk